Frances Heller Insider Profile
4 Followers
Frances Heller, Director at Larimar Therapeutics, holds 0.00 shares in Larimar Therapeutics (Ticker: LRMR), holds 4.22K shares in Bristol-Myers Squibb (Ticker: BMY), holds 17.25K shares in Exelixis (Ticker: EXEL). Most recently, Frances Heller Bought ― shares of Larimar Therapeutics on Oct 17, 2017 for an estimated value of $38.90K.
Frances Heller's Trading History
You May Also Like
Frances Heller insider profile FAQ
What is the percentage of profitable transactions made by Frances Heller?
The percentage of profitable transactions made by Frances Heller is 100%.
What is the average return per transaction made by Frances Heller?
The average return per transaction made by Frances Heller is 58.80%.
What stocks does Frances Heller hold?
Frances Heller holds: LRMR, BMY, EXEL stocks.
What was Frances Heller’s latest transaction?
Frances Heller’s latest transaction was an Informative Buy of $38.90K.
What was Frances Heller's most profitable transaction?
Frances Heller’s most profitable transaction was an Informative Buy of LRMR stock on October 17, 2017. The return on the trade was 190.80%.
What is Frances Heller's role in Larimar Therapeutics?
Frances Heller's role in Larimar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
